Benzimidazoles
US8288425B2 · kind B2 · utility
115Cited by
8References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 4, 2005 |
| Grant date | Oct 16, 2012 |
| Priority date | — |
| Expiry date | Jul 27, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to physiologically active compounds of the general formula (Ix)and compositions containing such compounds, and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (Ix), and to processes for their preparation. Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.